Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis
Abstract Background Tofacitinib is an oral Janus kinase inhibitor for treatment of ankylosing spondylitis (AS). Time to improvement in core domains of AS was estimated in tofacitinib-treated patients with AS. Methods This post hoc analysis used phase 3 trial data from patients with AS receiving tofa...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2024-05-01
|
| Col·lecció: | Arthritis Research & Therapy |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s13075-024-03313-w |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|